Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients
NCT00004451 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2005-12-01
Summary
This study will determine whether glucose facilitates memory in healthy elderly people and those with Parkinson's disease.
Conditions
- Parkinson Disease
Interventions
- DRUG
-
Glucose
Sponsors & Collaborators
-
University of Virginia
collaborator OTHER -
National Institute of Mental Health (NIMH)
lead NIH
Principal Investigators
-
Carol A. Manning · University of Virginia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1998-03-31
Countries
- United States
Study Locations
More Related Trials
-
Glucose Tolerance in Patients With an Idiopathic Parkinson's Disease
NCT01114321 ·Status: UNKNOWN ·Phase: NA
-
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study
NCT01469741 ·Status: COMPLETED ·Phase: NA
-
Diagnosis and Natural History Study of Patients With Neurological Conditions
NCT00001549 ·Status: COMPLETED
-
Prospective Memory Training in Parkinson Disease
NCT03582670 ·Status: COMPLETED ·Phase: NA
-
Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
NCT05998772 ·Status: RECRUITING
-
Neural Correlates of Cognition in Parkinson's Disease
NCT02975193 ·Status: COMPLETED ·Phase: NA
-
Cognitive Training in Parkinson's Disease
NCT05495997 ·Status: COMPLETED ·Phase: NA
-
Studying Automatic Movements in Patients With Parkinson's Disease
NCT00063661 ·Status: COMPLETED
-
Imaging Studies of Cognitive Impairment in Parkinson s Disease
NCT01862744 ·Status: COMPLETED
-
Vestibular Dysfunction and Glucose Metabolism
NCT02226536 ·Status: COMPLETED ·Phase: NA
-
Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia
NCT00917280 ·Status: COMPLETED
-
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
NCT02952391 ·Status: UNKNOWN
-
Quantification of Beta Activity in Routine EEG Recordings in Parkinson's Disease Patients
NCT03103347 ·Status: COMPLETED
-
Training Based On Declarative Memory Cues Improved Gait In Patients With Parkinson's Disease
NCT02600728 ·Status: COMPLETED ·Phase: NA
-
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
NCT01429207 ·Status: COMPLETED
-
Effects of Neuromodulation on Brain Electric Activity of Parkinson's Disease Patients
NCT04221659 ·Status: UNKNOWN ·Phase: NA
-
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
NCT06301282 ·Status: RECRUITING
-
Intravenous Plasma Treatment for Parkinson's Disease
NCT04202757 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Attention and Eye Movement in Parkinson's Disease
NCT06899022 ·Status: RECRUITING ·Phase: NA
-
Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease
NCT00026598 ·Status: COMPLETED
-
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
NCT05808504 ·Status: RECRUITING ·Phase: NA
-
Measures of Motor Impairment in Early Parkinson's Disease
NCT00291265 ·Status: COMPLETED
-
Cognitive Impairment in Parkinson's Disease Categorised in Accordance to Motor Symptoms
NCT00476372 ·Status: COMPLETED
-
Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood
NCT02104401 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Function in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis
NCT00334516 ·Status: COMPLETED